Rucaparib for the treatment of ovarian cancer

Cyriac, SL; Karakasis, K; Oza, AM

Oza, AM (reprint author), Univ Toronto, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Clin Canc Res Unit, Toronto, ON, Canada.; Oza, AM (reprint author), Univ Toronto, Princess Margaret Canc Ctr, Bras Drug Dev Program, Toronto, ON, Canada.

EXPERT OPINION ON ORPHAN DRUGS, 2018; 6 (2): 151

Abstract

Introduction: Poly adenosine diphosphate-ribose polymerase (PARP) inhibitors (PARPi) are evolving as one of the most promising therapies in ovarian ca......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索